Extra Intestinal Effects of Prebiotics and Probiotics

Prebiotics: Development & Application

Volumn , Issue , 2012, Pages 201-211

  Reid, Gregor ^a  

^a LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

Author keywords

Extra intestinal effects of prebiotics and probiotics; Lactobacilli in modulation down regulation of inflammation; Novel prebiotic applications and scope for extra intestinal sites; Prebiotic applications, targeted at the GI tract; Prebiotics probiotics, requiring full understanding of colonisation; Probiotics for respiratory infections atopic diseases; Probiotics resurgence, multidimensional due to antibiotic failures; Probiotics, preventing dental caries

Indexed keywords

EID: 84864229111     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470023150.ch9     Document Type: Chapter

References (54)

1. Anand, S. K., Medellin-Pena, M., Wang, H., Griffiths, M. W. Probiotic bacteria control expressions of virulence genes in E.coli 0157: H7 through a signaling pathway. Manuscript submitted 2006.
2. Arques, J. L., Fernandez, J., Gaya, P., Nunez, M., Rodriguez, E., Medina, M. Antimicrobial activity of reuterin in combination with nisin against food-borne pathogens. Int J Food Microbiol 2004; 95 (2): 225-9.
3. Bruce, A. W., Chadwick, P., Hassan, A., VanCott, G. F. Recurrent urethritis in women. Can Med Assoc J 1973; 108 (8): 973-6.
4. Brummel, T., Ching, A., Seroude, L., Simon, A. F., Benzer, S. Drosophila lifespan enhancement by exogenous bacteria. Proc Natl Acad Sci USA 2004; 101 (35): 12974-9.
5. Cadieux, P., Burton, J., Kang, C. Y., Gardiner, G., Braunstein, I., Bruce, A.W., Reid, G. Lactobacillus strains and vaginal ecology. JAMA 2002; 287: 1940-1.
6. Cauci, S., Guaschino, S., De Aloysio, D., Driussi, S., De Santo, D., Penacchioni, P., Quadrifoglio, F. Interrelationships of interleukin-8 with interleukin-1beta and neutrophils in vaginal fluid of healthy and bacterial vaginosis positive women. Mol Hum Reprod 2003; 9 (1): 53-8.
7. Chen, Y. C., Chang, W. H., Chang, Y., Huang, C. M., Sung, H. W. A natural compound (reuterin) produced by Lactobacillus reuteri for hemoglobin polymerization as a blood substitute. Biotechnol Bioeng 2004; 87 (1): 34-42.
8. Colodner, R., Edelstein, H., Chazan, B., Raz, R. Vaginal colonization by orally administered Lactobacillus rhamnosus GG. Isr Med Assoc J 2003; 5 (11): 767-9.
9. Devillard, E., Burton, J. P., Hammond, J.-A., Lam, D., Reid, G. Novel insight into the vaginal microflora in postmenopausal women under hormone replacement therapy as analyzed by PCRDenaturing Gradient Gel Electrophoresis. Eur J Obstet Gynecol 2004; 117 (1): 76-81.
10. Donlan, R. M., Costerton, J. W. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 2002; 15 (2): 167-93.
11. FAO/WHO. Evaluation of health and nutritional properties of powder milk and live lactic acid bacteria. Food and Agriculture Organization of the United Nations and World Health Organization Expert Consultation Report. http://www.fao.org/es/ESN/Probio/probio.htm posted 2001.
12. Gan, B. S., Kim, J., Reid, G., Cadieux, P., Howard, J. C. Lactobacillus fermentum RC-14 inhibits Staphylococcus aureus infection of surgical implants in rats. J Infect Dis 2002; 185: 1369-72.
13. Gibson, G. R., Roberfroid, M. B. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr 1995; 125: 1401-12.
14. Gluck, U., Gebbers, J. O. Ingested probiotics reduce nasal colonization with pathogenic bacteria (Staphylococcus aureus, Streptococcus pneumoniae, and beta-hemolytic streptococci). Am J Clin Nutr 2003; 77 (2): 517-20.
15. Holma, R., Salmenpera, P., Lohi, J., Vapaatalo, H., Korpela, R. Effects of Lactobacillus rhamnosus GG and Lactobacillus reuteri R2LC on acetic acid-induced colitis in rats. Scand J Gastroenterol 2001; 36 (6): 630-5.
16. Johnsborg, O., Diep, D. B., Nes, I. F. Structural analysis of the peptide pheromone receptor PlnB, a histidine protein kinase from Lactobacillus plantarum. J Bacteriol 2003; 185 (23): 6913-20.
17. Kalliomaki, M., Salminen, S., Arvilommi, H., Kero, P., Koskinen, P., Isolauri, E. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 2001; 357 (9262): 1076-9.
18. Kawai, Y., Ishii, Y., Arakawa, K., Uemura, K., Saitoh, B., Nishimura, J., Kitazawa, H., Yamazaki, Y., Tateno, Y., Itoh, T., Saito, T. Structural and functional differences in two cyclic bacteriocins with the same sequences produced by lactobacilli. Appl Environ Microbiol 2004; 70 (5): 2906-11.
19. Kelly, M. C., Mequio, M. J., Pybus,V. Inhibition of vaginal lactobacilli by a bacteriocin-like inhibitor produced by Enterococcus faecium 62-6: potential significance for bacterial vaginosis. Infect Dis Obstet Gynecol 2003; 11 (3): 147-56.
20. Laughton, J. M., Devillard, E., Heinrichs, D. E., Reid, G., McCormick, J. K. Inhibition of expression of a staphylococcal superantigen-like protein by a secreted signaling factor from Lactobacillus reuteri R.C. 14. Microbiology 2006. In press.
21. Lodinova-Zadnikova, R., Cukrowska, B., Tlaskalova-Hogenova, H. Oral administration of probiotic Escherichia coli after birth reduces frequency of allergies and repeated infections later in life (after 10 and 20 years). Int Arch Allergy Immunol 2003; 131 (3): 209-11.
22. Maassen, C. B., van Holten-Neelen, C., Balk, F., den Bak-Glashouwer, M. J., Leer, R. J., Laman, J. D., Boersma, W. J., Claassen, E. Strain-dependent induction of cytokine profiles in the gut by orally administered Lactobacillus strains. Vaccine 2000; 18 (23): 2613-23.
23. Mack, D. R., Ahrne, S., Hyde, L., Wei, S., Hollingsworth, M. A. Extracellular MUC3 mucin secretion follows adherence of Lactobacillus strains to intestinal epithelial cells in vitro. Gut 2003; 52 (6): 827-33.
24. Mastrandrea, F., Coradduzza, G., Serio, G., Minardi, A., Manelli, M., Ardito, S., Muratore, L. Probiotics reduce the CD34+hemopoietic precursor cell increased traffic in allergic subjects. Allerg Immunol (Paris) 2004; 36 (4): 118-22.
25. McCormick, J., Laughton, J., Heinrichs, D., Reid, G. Anti-infective signaling in Lactobacillus reuteri RC-14. International Scientific Association for Probiotics and Prebiotics, Copper Mountain, Colorado, 30 August 2004.
26. Meluleni, G. J., Grout, M., Evans, D. J., Pier, G. B. Mucoid Pseudomonas aeruginosa growing in a biofilm in vitro are killed by opsonic antibodies to the mucoid exopolysaccharide capsule but not by antibodies produced during chronic lung infection in cystic fibrosis patients. J Immunol 1995; 155 (4): 2029-38.
27. Montalto, M., Vastola, M., Marigo, L., Covino, M., Graziosetto, R., Curigliano, V., Santoro, L., Cuoco, L., Manna, R., Gasbarrini, G. Probiotic treatment increases salivary counts of lactobacilli: a double-blind, randomized, controlled study. Digestion 2004; 69 (1): 53-6.
28. Nase, L., Hatakka, K., Savilahti, E., Saxelin, M., Ponka, A., Poussa, T., Korpela, R., Meurman, J. H. Effect of long-term consumption of a probiotic bacterium, Lactobacillus rhamnosus GG, in milk on dental caries and caries risk in children. Caries Res 2001; 35: 412-20.
29. Nikawa, H., Makihira, S., Fukushima, H., Nishimura, H., Ozaki, Y., Ishida, K., Darmawan, S., Hamada, T., Hara, K., Matsumoto, A., Takemoto, T., Aimi, R. Lactobacillus reuteri in bovine milk fermented decreases the oral carriage of mutans streptococci. Int J Food Microbiol 2004; 95 (2): 219-23.
30. Rastall, R. A., Maitin, V. Prebiotics and synbiotics: towards the next generation. Curr Opin Biotechnol 2002; 13 (5): 490-8.
31. Reid, G., Bocking, A. The potential for probiotics to prevent bacterial vaginosis and preterm labor. Am J Obstet Gynecol 2003; 189 (4): 1202-8.
32. Reid, G., Bruce, A.W. Selection of Lactobacillus strains for urogenital probiotic applications. J Infect Dis 2001; 183 (S1): S77-80.
33. Reid, G., Bruce, A.W. Urogenital infections in women - Can probiotics help? Postgrad Med J 2003; 79: 429-32.
34. Reid, G., Burton, J. Use of Lactobacillus to prevent infection by pathogenic bacteria. Microbes Infect 2002; 4: 319-24.
35. Reid, G., Bruce, A. W., Taylor, M. Instillation of Lactobacillus and stimulation of indigenous organisms to prevent recurrence of urinary tract infections. Microecol Ther 1995; 23: 32-45.
36. Reid, G., Bruce, A.W., Tomeczek, L. The role of probiotics in the urogenital tract. In Human Health: The Contribution of Microorganisms S. A. W. Gibson (ed.). Springer Series in Applied Biology. Springer Verlag IFAB Communications, 1994, Ch. 7, pp. 111-8.
37. Reid, G., Cook, R. L., Bruce, A. W. Examination of strains of lactobacilli for properties which may influence bacterial interference in the urinary tract. J Urol 1987; 138: 330-5.
38. Reid, G., Bruce, A.W., Soboh, F., Mittelman, M. Effect of nutrient composition on the in vitro growth of urogenital Lactobacillus and uropathogens. Can J Microbiol 1988; 44: 1-6.
39. Reid, G., Bruce, A.W., Fraser, N., Heinemann, C., Owen, J., Henning, B. Oral probiotics can resolve urogenital infections. FEMS Microbiol Immunol 2001a; 30: 49-52.
40. Reid, G., Beuerman, D., Heinemann, C., Bruce, A. W. Probiotic Lactobacillus dose required to restore and maintain a normal vaginal flora. FEMS Immunol Med Microbiol 2001b; 32: 37-41.
41. Reid, G., Charbonneau, D., Gonzalez, S., Gardiner, G., Erb, J., Bruce, A.W. Ability of Lactobacillus GR-1 and RC-14 to stimulate host defences and reduce gut translocation and infectivity of Salmonella typhimurium. Nutraceut Food 2002; 7: 168-73.
42. Reid, G., Jass, J., Sebulsky, T., McCormick, J. Potential uses of probiotics in clinical practice. Clin Microbiol Rev 2003a; 16 (4): 658-72.
43. Reid, G., Charbonneau, D., Erb, J., Kochanowski, B., Beuerman, D., Poehner, R., Bruce, A.W. Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 healthy women. FEMS Immunol Med Microbiol 2003b; 35: 131-4.
44. Reid, G., Burton, J., Hammond, J.-A., Bruce, A. W. Nucleic acid based diagnosis of bacterial vaginosis and improved management using probiotic lactobacilli. J Med Food 2004; 7 (2): 223-8.
45. Romagnani, S. The increased prevalence of allergy and the hygiene hypothesis: missing immune deviation, reduced immune suppression, or both? Immunology 2004; 112 (3): 352-63.
46. Roos, K., Holm, S. E., Grahn, E., Lind, L. Alpha-streptococci as supplementary treatment of recurrent streptococcal tonsillitis: a randomized placebo-controlled study. Scand J Infect Dis 1993; 25 (1): 31-5.
47. Rosenfeldt, V., Benfeldt, E., Nielsen, S. D., Michaelsen, K. F., Jeppesen, D. L., Valerius, N. H., Paerregaard, A. Effect of probiotic Lactobacillus strains in children with atopic dermatitis. J Allergy Clin Immunol 2003; 111 (2): 389-95.
48. Sewankambo, N., Gray, R. H., Wawer, M. J., Paxton, L., McNaim, D., Wabwire-Mangen, F., Serwadda, D., Li, C., Kiwanuka, N., Hillier, S. L., Rabe, L., Gaydos, C. A., Quinn, T. C., Konde- Lule, J. HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis. Lancet 1997; 350 (9077): 546-50.
49. Sprunt, K., Leidy, G. The use of bacterial interference to prevent infection. Can J Microbiol 1988; 34 (3): 332-8.
50. Sprunt, K., Redman, W. Evidence suggesting importance of role of interbacterial inhibition in maintaining balance of normal flora. Ann Intern Med 1968; 68 (3): 579-90.
51. Stanaland, B. E. Therapeutic measures for prevention of allergic rhinitis/asthma development. Allergy Asthma Proc 2004; 25 (1): 11-5.
52. Sung, H. W., Chen, C. N., Liang, H. F., Hong, M. H. A natural compound (reuterin) produced by Lactobacillus reuteri for biological-tissue fixation. Biomaterials 2003; 24 (8): 1335-47.
53. Tzortzis, G., Baillon, M. L. A., Gibson, G. R., Rastall, R. A. Modulation of anti-pathogenic activity in canine derived Lactobacillus species by carbohydrate growth substrate. J Appl Microbiol 2004; 96: 552-9.
54. Velraeds, M. C., van der Mei, H. C., Reid, G., Busscher, H. J. Inhibition of initial adhesion of uropathogenic Enterococcus faecalis by biosurfactants from Lactobacillus isolates. Appl Environ Microbiol 1996; 62: 1958-63.